It's water-soluble, so your body flushes out what it doesn't use, and there's no established toxic dose for healthy people
Studies comparing delivery methods show topical formulations achieve only a fraction of the bioavailability that subcutaneous injection provides
Patients taking certain medications (e.g., chloramphenicol may reduce the effectiveness of B12 therapy) or with risk factors for B12 deficiency (metformin use, proton pump inhibitors, nitrous oxide exposure, vegan diet) should discuss these with their healthcare provider
Malabsorption disorders : Patients with conditions like Crohns disease, celiac disease, or pernicious anemia that affect the absorption of nutrients may require more frequent injections, approximately every 4-8 weeks
[6] These findings support the interpretation that NO-related pathways may contribute to some observed BPC-157-associated effects in laboratory systems, but they do not prove that BPC-157 directly binds NOS enzymes or directly controls NO production